Efficacy and safety of 1.5% levofloxacin otic solution for the treatment of otitis media in a multicenter, randomized, double-blind, parallel-group, placebo-controlled, phase III study.

[1]  J. Killian,et al.  Benzalkonium Chloride: A Known Irritant and Novel Allergen , 2016, Dermatitis : contact, atopic, occupational, drug.

[2]  T. Most,et al.  Risk factors for sensorineural hearing loss in chronic otitis media , 2013, Acta oto-laryngologica.

[3]  C. Gamble,et al.  Topical quinolone vs. antiseptic for treating chronic suppurative otitis media: a randomized controlled trial , 2005, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[4]  Į. Kaygusuz,et al.  [Efficacy of topical ciprofloxacin and tobramycin in combination with dexamethasone in the treatment of chronic suppurative otitis media]. , 2002, Kulak burun bogaz ihtisas dergisi : KBB = Journal of ear, nose, and throat.

[5]  W. Craig.  Does the dose matter? , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  L. Kasemsuwan,et al.  A double blind, prospective trial of topical ciprofloxacin versus normal saline solution in the treatment of otorrhoea. , 1997, Clinical otolaryngology and allied sciences.

[7]  A. Koc,et al.  Treatment of chronic ear disease. Topical ciprofloxacin vs topical gentamicin. , 1995, Archives of otolaryngology--head & neck surgery.

[8]  T. Nishino,et al.  In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacin. , 1990, The Journal of antimicrobial chemotherapy.

[9]  S. Esposito,et al.  Topical and oral treatment of chronic otitis media with ciprofloxacin. A preliminary study. , 1990, Archives of otolaryngology--head & neck surgery.

[10]  T. Une,et al.  In vitro activity of DR-3355, an optically active ofloxacin , 1988, Antimicrobial Agents and Chemotherapy.

[11]  I. Hayakawa,et al.  Synthesis and antibacterial activities of optically active ofloxacin , 1986, Antimicrobial Agents and Chemotherapy.

[12]  Hisashi Takahashi,et al.  [The history of the development and changes of quinolone antibacterial agents]. , 2003, Yakushigaku zasshi.

[13]  Á. Ramos,et al.  Utilización del ciprofloxacino tópico en la otitis media crónica supurada , 2003 .

[14]  O. Nawasreh,et al.  Topical ciprofloxacin versus topical gentamicin for chronic otitis media. , 2001, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[15]  Á. Ramos Macias,et al.  [Antimicrobial therapy in chronic suppurative otitis media]. , 1999, Acta otorrinolaringologica espanola.

[16]  J. Viñas,et al.  [Multicenter study comparing the efficacy and tolerance of topical ciprofloxacin (0.3%) versus topical gentamicin (0.3%) in the treatment of simple, non-cholesteatomaous chronic otitis media in the suppurative phase]. , 1995, Anales otorrinolaringologicos ibero-americanos.